Related Experiment Video
Updated: Jun 19, 2025

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Causal relationship between circulating immune cells and inflammatory bowel disease: A Mendelian randomization
Shan Li1, Dujuan Mao1, Quanshui Hao1
1Department of Anesthesiology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang, Hubei, China.
This study found specific immune cell differences linked to Crohn disease risk, but not to ulcerative colitis or general inflammatory bowel disease. These findings may inform new immunotherapies for Crohn disease.
Area of Science:
- Immunology
- Gastroenterology
- Genetics
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn disease and ulcerative colitis (UC), is an immune-mediated condition.
- The precise link between circulating immune cells and IBD pathogenesis remains incompletely understood.
- Understanding these relationships is crucial for developing targeted immunotherapies.
Purpose of the Study:
- To investigate the causal relationship between circulating immune cell phenotypes and IBD, Crohn disease, and UC.
- To identify specific immune cell markers associated with the risk of developing these conditions.
- To explore potential therapeutic targets for IBD based on immune cell profiles.
Main Methods:
- A bidirectional two-sample Mendelian randomization (MR) study was employed.
- Genome-wide association study summary statistics for immune cell phenotypes and IBD traits were utilized.
- Inverse-variance-weighted (IVW) method was the primary analysis, with MR-Egger-intercept tests for pleiotropy and FDR correction.
Main Results:
- No significant causal relationship was found between immune cell phenotypes and IBD or UC after FDR adjustment.
- Four immune cell characteristics were causally associated with Crohn disease.
- Increased HLA-DR+ CD4+ T cells correlated with higher Crohn disease risk; decreased IgD- CD27- B cells, CD28 on CD39+ regulatory T cells, and naive CD4+ T cells correlated with lower risk.
Conclusions:
- Specific immune cell profiles are causally linked to Crohn disease development, but not to UC or general IBD.
- The identified immune cell phenotypes offer potential biomarkers and therapeutic targets for Crohn disease.
- Further research can leverage these findings to advance immunotherapies for IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

